Transcarent Launches Bundled Payment Model for Advanced Cancer Care

Author : Mary Brown | Published On : 27 Aug 2026

Healthcare navigation platform Transcarent has introduced a first-of-its-kind bundled payment model to support advanced cancer therapies delivered in community settings. The model extends fixed-rate bundled pricing to complex immunotherapies, specifically targeting CAR T-cell and bispecific T-cell engager (BiTE) treatments. By establishing value-based bundled arrangements with high-quality regional and community-based providers, Transcarent allows self-insured employers to stabilize rising oncology expenses while offering patients local access to life-saving medical care.

Traditionally, breakthrough cancer treatments cost hundreds of thousands of dollars and remain restricted to select academic medical centers. This dynamic forces patients and their caregivers to travel long distances while navigating complex referral processes and extensive prior authorization delays. Transcarent's payment framework removes these geographic and operational hurdles, expanding access to cutting-edge immunotherapies and delivering potential employer savings of up to $150,000 per care episode.

Personalized Navigation and Support Through Certified Navigators

To support members undergoing advanced immunotherapies, Transcarent embeds specialized, dedicated assistance directly into its Cancer Care Centers of Excellence (COE) framework. Patients receiving CAR T or BiTE therapies gain direct access to Oncology Nurse Navigators certified through the American Cancer Society's LION program.

These certified navigators act as a central point of contact throughout the entire care journey, guiding patients from initial specialist referral through long-term recovery. The navigation team simplifies complex clinical steps, coordinates care among multiple providers, explains treatment options, and proactively addresses non-clinical barriers to care. This structured approach helps relieve emotional and logistical stress for patients and their families during critical treatment windows.

Expanding Community Oncology Access via Strategic Partnerships

A key element of Transcarent’s expanded cancer care framework is its strategic partnership with nationwide oncology management organizations, including Vantris Oncology. Vantris brings together community oncology practices across the country, building a robust physical infrastructure for value-based cancer care delivery.

By combining Vantris' national provider network with Transcarent's value-based payment architecture and integrated navigation platform, the joint effort enables high-quality, complex cancer care outside traditional academic settings. This collaboration establishes a consistent standard of care across regional sites, aligning quality, clinical accessibility, and financial predictability to make advanced oncology treatments both scalable and equitable.

Discover Health Tech Insiders for the latest advancements in medical technology and trusted strategic insights shaping the future of tech-driven healthcare transformation.